Abstract:BACKGROUND & OBJECTIVE:Activation of mammalian target of rapamycin(mTOR)has been associated to poor prognosis of glioma patients.This study was designed to investigate the regulatory mechanisms of mTOR signaling on self-renewal of glioma stem cells(GSCs).METHODS:CD133+GSCs have been isolated by using CD133 magnetic beads from human glioblastoma specimens and glioma cell line SKMG-4 and were propagated without serum in vitro.Molecular markers for glioma stem cells(CD133,nestin,Sox-2,GFAP and TuJ1) were detected by immunofluorescent staining.mTOR signaling passway was inactivated by rapamycin treatment.Self-renewal was tested by tumor sphere formation assay.The phosphorylation status of mTOR components was determined by Western blot analysis.All statistical analyses were performed using the SPSS software package,version11.0.RESULTS:The levels of p-S6K and p-S6,components of mTOR signaling,were higher in CD133+GSCs than matched CD133-cells.GSC fractions also expressed high levels of Bmi-1,a key regulator of neural stem cell self-renewal.Inhibition of the mTOR signaling pathway by rapamycin resulted in a reduction of.tumor sphere formation,which is indenpendent from autophagy since 3-MA did not revise the effect of rapamycin.Rapamycin treatment also resulted in differentiation of the CD133+GSCs.CONCLUSION:Disruption of mTOR signals can impair stem cell selfrenewalandconcomitantly trigger lineage differentiation.

mTOR Signaling Pathway Regulates Self-renewal of CD133 Positive Glioma Stem Cells